Global Arthritis Partnering Deals and Agreements Analysis 2010-2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Arthritis Partnering 2010 to 2016" report to their offering.

The Global Arthritis Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Global Therapy Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:

-In-depth understanding of deal trends since 2010

-Access to headline, upfront, milestone and royalty data

-Comprehensive access to multiple deals entered into by the world's biopharma companies since 2010

-Insight into key deal terms included in contracts, where disclosed

-Understand the key deal terms companies have agreed in deals

-Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Key Topics Covered:

Executive Summary

1 Therapy partnering trends in numbers

  • By year
  • Most active
  • By industry sector
  • By deal type
  • By technology type
  • By stage of development

2 Most active dealmakers

3 Partnering deals directory

  • By company A-Z
  • By deal value
  • By industry sector
  • By deal type
  • By stage of development
  • By technology area

4 Partnering deals with a contract document

5 M&A in numbers

  • M&A in numbers - by year
  • 6 M&A deals directory
  • M&A deals directory - by company A-Z
  • M&A deals directory - by deal value

7 Financing in numbers

  • By year
  • By financing type

8 Financing deals directory

  • By company A-Z
  • By deal value
  • By financing type

Companies Mentioned

  • Abbott
  • Aspen Pharmacare
  • Astellas
  • AstraZeneca
  • Baxter International
  • Bayer
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • CSL
  • Daiichi Sankyo
  • Dainippon Sumitomo
  • Eisai
  • Eli Lilly
  • Endo Pharmaceuticals
  • Forest Laboratories
  • Galderma
  • Gilead Sciences
  • GlaxoSmithKline
  • Grifols
  • Hospira
  • Johnson & Johnson
  • Merck & Co
  • Merck KGaA
  • Mitsubishi Tanabe
  • Novartis
  • Novo Nordisk
  • Otsuka
  • Pfizer
  • Purdue
  • Roche
  • Sanofi
  • Warner Chilcott
  • Watson

For more information about this report visit http://www.researchandmarkets.com/research/hll35k/global_arthritis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs